GL1X · GenesisL1 explorer

MolNFT v1 · #155891 · protein

Discovery of a dual inhibitor of NQO1 and GSTP1 for treating malignant glioblastoma

6LLX · Glutathione S-transferase P: “Discovery of a dual inhibitor of NQO1 and GSTP1 for treating malignant glioblastoma”. X-ray diffraction, 1 ligand (GSH), 4 pockets (best druggability 0.73). MolNFT v1 #155891 on GenesisL1: 3D structure…

PDB
6LLX
Type
protein
Length
424 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glutathione S-transferase P
EC
2.5.1.18
UniProt
P09211
Ligands
GSH
Pockets
4 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 60% helix, 8% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlutathione S-transferase P (EC 2.5.1.18)protein20961% helix, 9% strandP09211
BGlutathione S-transferase P (EC 2.5.1.18)protein21560% helix, 8% strandP09211

Ligands and binding sites

  • GSH · Glutathione · ligand · 2 copies · chains A, B
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17000.730.7986GSH
2830.350.7518empty
3930.340.7417empty
4720.290.7316empty

Interfaces

1 interface between chains.

  • A–B · 1270 Ų buried · 16 hydrogen bonds · protein-protein

Compared structures

  • 6LLX · Discovery of A Dual Inhibitor of NQO1 and GSTP1 for Treating Malignant Glioblastoma · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.